[go: up one dir, main page]

GR20020100011A - Use of melanin for the prevention or treatment of any type of hypercholesterolemia, hyperlipidemia and any other lipid disorder in humans and animals - Google Patents

Use of melanin for the prevention or treatment of any type of hypercholesterolemia, hyperlipidemia and any other lipid disorder in humans and animals

Info

Publication number
GR20020100011A
GR20020100011A GR20020100011A GR2002100011A GR20020100011A GR 20020100011 A GR20020100011 A GR 20020100011A GR 20020100011 A GR20020100011 A GR 20020100011A GR 2002100011 A GR2002100011 A GR 2002100011A GR 20020100011 A GR20020100011 A GR 20020100011A
Authority
GR
Greece
Prior art keywords
animals
melanin
hyperlipidemia
humans
prevention
Prior art date
Application number
GR20020100011A
Other languages
Greek (el)
Inventor
Νικολαος Αβραμιδης
Αγγελικη Κουρουνακη
Λυγερη Χατζηπετρου-Κουρουνακη
Original Assignee
Νικολαος Αβραμιδης
Αγγελικη Κουρουνακη
Λυγερη Χατζηπετρου-Κουρουνακη
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Νικολαος Αβραμιδης, Αγγελικη Κουρουνακη, Λυγερη Χατζηπετρου-Κουρουνακη filed Critical Νικολαος Αβραμιδης
Priority to GR20020100011A priority Critical patent/GR20020100011A/en
Publication of GR20020100011A publication Critical patent/GR20020100011A/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

he product melanin is extracted from the leaves of tea under specific conditions, is purified, condensed and purified even further and freeze-dried for the use in the prevention or treatment of anytype of hypercholestolemia, hyperlipidemia and any other lipid disorder, atherosclerosis of atheromatosis in humans and animals. Administration of this product parenterally or orally to hypercholesterolemic animals induced a significant reduction of the levels of total cholesterol, total triglykerides and of LDL-cholesterol in comparison with the control group. Melanin did not show any signs of toxicity or side effects on the experiment animals.
GR20020100011A 2002-01-16 2002-01-16 Use of melanin for the prevention or treatment of any type of hypercholesterolemia, hyperlipidemia and any other lipid disorder in humans and animals GR20020100011A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GR20020100011A GR20020100011A (en) 2002-01-16 2002-01-16 Use of melanin for the prevention or treatment of any type of hypercholesterolemia, hyperlipidemia and any other lipid disorder in humans and animals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20020100011A GR20020100011A (en) 2002-01-16 2002-01-16 Use of melanin for the prevention or treatment of any type of hypercholesterolemia, hyperlipidemia and any other lipid disorder in humans and animals

Publications (1)

Publication Number Publication Date
GR20020100011A true GR20020100011A (en) 2003-09-24

Family

ID=29559770

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20020100011A GR20020100011A (en) 2002-01-16 2002-01-16 Use of melanin for the prevention or treatment of any type of hypercholesterolemia, hyperlipidemia and any other lipid disorder in humans and animals

Country Status (1)

Country Link
GR (1) GR20020100011A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000010507A2 (en) * 1998-08-21 2000-03-02 The Children's Medical Center Corporation Use of melanin for inhibition of angiogenesis and macular degeneration
WO2001018125A1 (en) * 1999-09-09 2001-03-15 Carlo Ghisalberti Synthetic vegetal melanins, process for their production and compositions containing thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000010507A2 (en) * 1998-08-21 2000-03-02 The Children's Medical Center Corporation Use of melanin for inhibition of angiogenesis and macular degeneration
WO2001018125A1 (en) * 1999-09-09 2001-03-15 Carlo Ghisalberti Synthetic vegetal melanins, process for their production and compositions containing thereof

Similar Documents

Publication Publication Date Title
WO1998040375A3 (en) COMBINATION OF ILEAL BILE ACID TRANSPORT INHIBITING BENZOTHIEPINES AND HMG Co-A REDUCTASE INHIBITORS
KR20050021026A (en) Pharmaceutical composition for prevention and treatment of disease causing from abnormality of immune system comprising old platycodon extracts
EP1299374A4 (en) Novel non-psychotropic cannabinoids
GB2333453A (en) Colostrinin and uses thereof
WO2002028425A3 (en) Methods for treating muscle injuries
MXPA04005456A (en) Acetylene derivatives having mglur 5 antagonistic activity.
SI0801564T1 (en) Use of nebivolol as an anti-atherogenic
NZ512533A (en) A combination of IBAT inhibitor and nicotinic acid derivative to treat hypercholesterolemia, hyperlipidemic or atherosclerotic conditions
AU8995598A (en) Product and method for the treatment of hyperlipidemia
AU4331400A (en) Neurotrophic substituted pyrimidines
CA2245123A1 (en) Use of rosaceae plant extract as a bradykinin antagonist
GR3032012T3 (en) Sectional overhead door
AU8736798A (en) Use of cholinesterase inhibitors for treating attention deficit disorders
BR9712992A (en) Sheet processing machine.
WO2002039953A3 (en) Texaphyrin coordination compounds and uses thereof
GR20020100011A (en) Use of melanin for the prevention or treatment of any type of hypercholesterolemia, hyperlipidemia and any other lipid disorder in humans and animals
AU7918500A (en) Substituted diazepanes
IL157050A0 (en) 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
TW200602042A (en) Heterocyclic derivatives for treatment of hyperlipidemia and related diseases
WO2005049056A3 (en) Immune modulator comprising whole cell rhodococcus, gordonia, nocardia, dietzia, tsukamurella or nocardioides bacteria
BRPI0409609A (en) reverse cholesterol transport mediators for the treatment of hypercholesterolemia
BR9911787A (en) 1h-indazoles replaced by 1.5- and 3-o with antiasthmatic, antiallergic, inflammation inhibitor, immunomodulatory and neuroprotective effects, processes for their preparation and use as a medicine
MXPA02007403A (en) 4 pyridyl and 2,4 pyrimidinyl substituted pyrrole derivatives and their use in pharmacy.
GR20020100012A (en) Use of guaiazulene for the prevention or treatment of any type of hypercholesterolemia, hyperlipidemia and any other lipid disorder in humans and animals
WO2006033891A3 (en) Compounds for the treatment of dyslipidemia and other lipid disorders